* Minerva Neurosciences Inc NERV.OQ NERV.O is expected
to show
no change in quarterly revenue when it reports results on May
15.
*
* Refinitiv's mean analyst estimate for Minerva
Neurosciences Inc
is for a loss of $1.63 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $8, above its last closing price
of $7.75.
This summary was machine generated May 12 at 16:11 GMT. All
figures in US dollars unless otherwise stated